Catalyst Wire Dossier Catalyst Wire Dossier

AZD6765

lanicemine · AstraZeneca
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for AZD6765, covering 2011-01-21 to 2014-10-21. Get the full timeline:

Most recent: Clinical Trial Update: This is a Study to Determine the Antidepressant Effects of AZD6765 [Phase 2]

See pricing